Literature DB >> 31505162

Models of poststroke depression and assessments of core depressive symptoms in rodents: How to choose?

Xi Tao1, Wanlin Yang2, Shuzhen Zhu2, Rongfang Que2, Chujuan Liu3, Tao Fan4, Jia Wang5, Danheng Mo6, Zhuohua Zhang7, Jieqiong Tan7, Kunlin Jin8, Midori A Yenari9, Tao Song10, Qing Wang11.   

Abstract

Our previous studies have indicated that depression and declined cognition have been involved in some neurodegenerative diseases including Stroke, Parkinson's diseases and Vascular Parkinsonism. Post-stroke depression (PSD) is the most common psychiatric disorder following a stroke and has high morbidity and mortality. Studies on PSD are increasingly common, but the specific mechanisms remain unknown. Current research mainly includes clinical and animal aspects. Questionnaires and peripheral blood examination are two of the most common methods used to study clinical PSD. The results of questionnaires are influenced by multiple factors such as disease history, education background, occupation, economic status, family relationships and social support. There are certain limitations to blood sample testing; for example, it is influenced by cerebrovascular diseases and some other disruptions of the internal environment. It is difficult for either method to fully clarify the pathophysiological mechanism of PSD. Animal models provide alternative methods to further understand the pathophysiological mechanisms of PSD, such as the involvement of neuronal circuits and cytokines. More than ten animal models of PSD have been developed, and new models are constantly being introduced. Therefore, it is important to choose the appropriate model for any given study. In this paper, we will discuss the characteristics of the different models of PSD and comment on the advantages and disadvantages of each model, drawing from research on model innovation. Finally, we briefly describe the current assessment methods for the core symptoms of PSD models, point out the shortcomings, and present the improved sucrose preference test as a rational evaluation of anhedonia.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Assessment; Core symptom; Model; Post stroke depression

Mesh:

Year:  2019        PMID: 31505162     DOI: 10.1016/j.expneurol.2019.113060

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus.

Authors:  Alireza Partoazar; Zahra Seyyedian; Golnaz Zamanian; Partow Mirzaee Saffari; Ahad Muhammadnejad; Ahmad Reza Dehpour; Ramin Goudarzi
Journal:  Psychopharmacology (Berl)       Date:  2021-02-11       Impact factor: 4.530

Review 2.  Protective effects of mesenchymal stem cells on ischemic brain injury: therapeutic perspectives of regenerative medicine.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2020-11-24       Impact factor: 1.522

3.  Integrative Analysis of lncRNA and mRNA and Profiles in Postoperative Delirium Patients.

Authors:  Yuxiang Song; Xiaoyan Wang; Aisheng Hou; Hao Li; Jingsheng Lou; Yanhong Liu; Jiangbei Cao; Weidong Mi
Journal:  Front Aging Neurosci       Date:  2021-05-19       Impact factor: 5.750

4.  Aconitate decarboxylase 1 suppresses cerebral ischemia-reperfusion injury in mice.

Authors:  Thomas M Vigil; Ryan A Frieler; KiAundra L Kilpatrick; Michael M Wang; Richard M Mortensen
Journal:  Exp Neurol       Date:  2021-10-23       Impact factor: 5.330

5.  Delayed PARP-1 Inhibition Alleviates Post-stroke Inflammation in Male Versus Female Mice: Differences and Similarities.

Authors:  Jian Chen; Xiaoxi Li; Siyi Xu; Meijuan Zhang; Zhengzheng Wu; Xi Zhang; Yun Xu; Yanting Chen
Journal:  Front Cell Neurosci       Date:  2020-04-03       Impact factor: 5.505

6.  Programmed Cell Deaths and Potential Crosstalk With Blood-Brain Barrier Dysfunction After Hemorrhagic Stroke.

Authors:  Yuanjian Fang; Shiqi Gao; Xiaoyu Wang; Yang Cao; Jianan Lu; Sheng Chen; Cameron Lenahan; John H Zhang; Anwen Shao; Jianmin Zhang
Journal:  Front Cell Neurosci       Date:  2020-04-03       Impact factor: 5.505

7.  P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD.

Authors:  Jiangnan Ma; Jinzhao Gao; Mengyue Niu; Xiaona Zhang; Jing Wang; Anmu Xie
Journal:  Front Aging Neurosci       Date:  2020-11-04       Impact factor: 5.750

8.  Morinda officinalis oligosaccharides alleviate depressive-like behaviors in post-stroke rats via suppressing NLRP3 inflammasome to inhibit hippocampal inflammation.

Authors:  Zhifang Li; Hexiang Xu; Yi Xu; Guanfeng Lu; Qiwei Peng; Jiefang Chen; Rentang Bi; Jianzhuang Li; Shengcai Chen; Hongkai Li; Huijuan Jin; Bo Hu
Journal:  CNS Neurosci Ther       Date:  2021-09-24       Impact factor: 5.243

9.  proBDNF expression induces apoptosis and inhibits synaptic regeneration by regulating the RhoA-JNK pathway in an in vitro post-stroke depression model.

Authors:  Bangkun Yang; Lesheng Wang; Ying Nie; Wei Wei; Wenping Xiong
Journal:  Transl Psychiatry       Date:  2021-11-10       Impact factor: 6.222

10.  Fibrinogen is an Independent Risk Factor for White Matter Hyperintensities in CADASIL but not in Sporadic Cerebral Small Vessel Disease Patients.

Authors:  Xingfang Guo; Bin Deng; Lizi Zhong; Fen Xie; Qing Qiu; Xiaobo Wei; Wenya Wang; Jiangping Xu; Ganqiang Liu; Wong Peter Tsun Hon; Midori A Yenari; Shuzhen Zhu; Qing Wang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.